Picture of Nexstim Oyj logo

NXTMH — Nexstim Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Nexstim Specifies Its Guidance For 2023

Jan 2 (Reuters) - Nexstim Oyj  NXTMH.HE :
    * SPECIFIES ITS GUIDANCE FOR 2023
    * EXPECTS COMPARABLE NET SALES WILL GROW IN 2023 AND ITS
EBITDA
(OPERATING RESULT BEFORE DEPRECIATIONS) FOR FINANCIAL YEAR WILL
BE NEGATIVE
    * NET SALES AND COMPARABLE NET SALES FOR FULL YEAR OF 2023
ARE
ESTIMATED TO BE APPROX. EUR 7 MILLION
    * SEES 2023 EBITDA BETWEEN EUR -0.6 AND -0.3 MILLION
    * CHANGE IN BUSINESS FORECASTS DUE TO PURCHASING DECISION OF
NBS 5
SYSTEMS TO TWO HOSPITALS IN US, ONE IN EUROPE BEING POSTPONED TO
2024
    * SECOND HALF OF 2023 WILL BE RECORD BREAKING IN TERMS OF
NET
SALES AND POSITIVE EBITDA

Source text for Eikon:  ID:nGNE6j9MZr 
Further company coverage:  NXTMH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

Recent news on Nexstim Oyj

See all news